Pfizer On Track To Settle Rapamune Investigation; Protonix Probe Still Unresolved

Pfizer has reached an agreement-in-principle with the Department of Justice in the Rapamune investigation and taken a charge of $491 million; Novartis settles allegations over the marketing of Elidel for $19.9 million.